Biosimilars Canada has compiled a list of news stories from Canada and abroad about biosimilars that may be of interest to readers. These links to third-party websites are provided for informational purposes only, and do represent an endorsement from our organization. Biosimilars Canada’s statements and news releases are available here.
Only one year after the official coming into force of the biosimilar transition, they have already had a major impact on the Quebec health care system. They have enabled thousands of patients to be treated safely, while generating $140 million in savings that have been reinvested in patient care.
In this CFRB Newstalk 1010 interview Biosimilars Canada President Jim Keon discusses how Ontario can save money and support pharmaceutical investment through the implementation of a biosimilars switching policy.
As the Generics Bulletin reports, half of Canada’s provinces have now announced biosimilar switching policies.
Report from the AJMC Center for Biosimilars on Nova Scotia’s new biosimilar switching initiative.